查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1887155

牛疫苗市場規模、佔有率、成長及全球產業分析：依類型、應用和地區劃分的洞察與預測（2024-2032 年）

Bovine Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 167 Pages | 商品交期: 請詢問到貨日

價格

牛隻疫苗市場成長驅動因素

隨著畜牧業健康對全球乳製品和肉品產業的永續發展日益重要，全球牛隻疫苗市場持續穩定成長。最新數據顯示，受疾病發病率上升和對預防性獸醫保健日益重視的推動，預計該市場規模將在 2024 年達到 37.9 億美元，2025 年增至 39 億美元，並在 2032 年進一步擴大至 54.6 億美元。北美地區在 2024 年佔市場主導地位，市佔率達 46.44%，主要得益於該地區乳製品消費量高、生物安全標準嚴格以及疫苗接種計劃廣泛。

牛疫苗在保護牛免受口蹄疫、出血性敗血症、黑腿病和布魯氏菌病等傳染病的侵害方面發揮著至關重要的作用。世界動物衛生組織 (OIE) 的報告顯示，口蹄疫影響全球 77% 的牲畜，凸顯了高效疫苗接種的迫切需求。同時，乳製品需求的成長也顯著推動了疫苗的普及。世界自然基金會 (WWF) 強調，全球有 2.7 億頭乳牛用於產奶，這給農民帶來了沉重的負擔，他們需要預防可能損害牛群生產力的疫情爆發。

市場驅動因素

牲畜疾病的日益普遍和乳製品需求的成長是關鍵的成長驅動因素。光是乳房炎就影響 100 頭乳牛中的 30 頭，由於提前淘汰和牛奶品質下降，每年造成農民高達 12,771.40 美元的損失。鑑於這些經濟風險，農民優先考慮預防性疫苗接種計劃，以保障其盈利能力和牲畜健康。

人們對動物福利的日益重視和農場管理實踐的改進進一步加速了疫苗的普及。隨著消費者對更安全、更高品質的乳製品和肉類產品的需求不斷增長，生產者越來越依賴疫苗接種來降低疾病發生率並提高牲畜生產力。

市場限制因子

發展中國家疫苗接種覆蓋率低仍是重大障礙。獸醫基礎設施匱乏、農民知識不足、經濟挑戰是疫苗接種率低的主要原因。根據聯合國糧農組織的數據，發展中國家的牲畜死亡率仍然很高，每年有20%的反芻動物過早死亡，其中一半是由於傳染病造成的。低收入地區缺乏持續的疫苗接種持續阻礙全球市場的擴張。

市場機會

研發工作正為先進疫苗技術創造機會。 2024年8月，密蘇里大學研發出一種針對牛無形體病（一種嚴重的蜱傳疾病）的疫苗。生物技術的進步，例如重組疫苗和基於基因組分析的平台，正在推動靶向疫苗的快速研發。這項創新研發流程正為控制新出現的牲畜疾病開闢新的成長途徑。

市場趨勢

mRNA疫苗的研發是正在改變獸用疫苗產業的新趨勢。這些疫苗具有高度適應性、快速生產以及針對多種病原體的能力。 2025年2月，禮來公司與MedGene公司合作，將一種針對乳牛高致病性禽流感（HPAI）的mRNA疫苗商業化。預計這些突破將在未來十年重塑牛病預防策略。

市場區隔洞察

依產品分類

由於滅活疫苗的高效性和不斷增加的核准產品，其在2024年佔了最大的市場佔有率。 2024年5月，勃林格殷格翰推出了BULTAVO 3，一種針對藍舌病毒3型血清型的滅活疫苗。

依給藥途徑分類

2024年，腸外給藥途徑憑藉其高效性和快速的免疫反應，引領了市場。碩騰公司於2023年批准了針對牛支原體的Protivity疫苗，進一步鞏固了該途徑的領先地位。

依分銷管道分類

受政府主導的大規模疫苗接種計劃的推動，獸醫診所佔了最大的市場佔有率。印度於 2025 年啟動的牲畜多重疾病疫苗接種計畫 (LHDCP) 促進了以醫院為基礎的疫苗分發。

區域展望

北美

預計到 2024 年，北美市場規模將達到 17.6 億美元，這主要得益於其完善的獸醫基礎設施和不斷增長的乳製品產量。美國在該地區處於領先地位，投入大量資金進行研發，包括牛呼吸道疾病的新疫苗。

歐洲

政府主導的人畜共患病控制計畫和疫苗試驗，例如英國於 2023 年啟動的結核病疫苗試驗，正在推動市場成長。

亞太地區

由於乳製品產量不斷增長和疾病負擔沉重，預計亞太地區將實現強勁增長。在印度，預計到 2024 年，水牛奶產量將達到 1.107 億噸，這將推動疫苗需求的成長。

拉丁美洲、中東和非洲

由於牲畜數量增加以及政府主導的疫苗接種工作（例如阿布達比 2024-2025 年的牲畜疫苗接種運動），預計這些地區的需求將溫和增長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：主要發現

  • 主要國家和地區牛病概況（2024 年）
  • 主要國家和地區監管狀況（2024 年）
  • 牛病疫苗概況
  • 主要公司新產品發布
  • 主要產業趨勢（併購、合作等）
  • 新冠疫情的影響全球牛隻疫苗市場概覽

第五章 全球牛隻疫苗市場分析、洞察與預測（2019-2032）

  • 市場分析、洞察與預測：依產品分類
    • 滅活​​疫苗
    • 減毒活疫苗
    • 重組疫苗
    • 其他
  • 市場分析、洞察與預測：依給藥途徑分類
    • 口服
    • 注射
    • 鼻腔給藥
  • 市場分析、洞察與預測：依銷售管道分類
    • 獸醫院
    • 獸醫診所
    • 藥局
    • 其他
  • 市場分析、洞察與預測：依…區域
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美牛隻疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲牛疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞半島
    • 歐洲其他地區

第八章亞太地區牛隻疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：拉丁美洲牛疫苗市場分析、洞察與預測（2019-2032）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章：中東與非洲牛疫苗市場分析、洞察與預測（2019-2032）

  • 依國家/地區
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析 (2024)
  • 公司簡介
    • 禮來動保 (Elanco)
    • 喜寶 (HIPRA)
    • 勃林格殷格翰國際有限公司 (Boehringer Ingelheim International GmbH)
    • 維克 (Virbac)
    • 默克公司 (Merck & Co., Inc.)
    • 碩騰服務有限公司 (Zoetis Services LLC)
    • 西華 (Ceva)
    • 印度免疫學有限公司 (Indian Immunologicals Ltd.)
Product Code: FBI112837

Growth Factors of bovine vaccines Market

The global bovine vaccines market continues to grow steadily as livestock health becomes increasingly important for sustaining the global dairy and meat industry. According to the latest data, the market was valued at USD 3.79 billion in 2024, is expected to rise to USD 3.90 billion in 2025, and further expand to USD 5.46 billion by 2032, supported by rising disease prevalence and increasing focus on preventive veterinary care. In 2024, North America led the market with a 46.44% share, driven by high dairy consumption, strong biosecurity standards, and extensive vaccination programs.

Bovine vaccines play a crucial role in protecting cattle from infectious diseases such as Foot and Mouth Disease (FMD), hemorrhagic septicemia, black quarter, brucellosis, and more. The World Organization for Animal Health reports that FMD affects 77% of the global livestock population, underscoring the critical need for efficient immunization. Meanwhile, rising demand for dairy products is significantly boosting vaccine adoption. The World Wildlife Fund highlights that 270 million dairy cows are raised worldwide for milk production, placing enormous pressure on farmers to prevent outbreaks that could damage herd productivity.

Market Drivers

Rising livestock disease prevalence and increasing dairy demand are the primary growth catalysts. Mastitis alone affects 30 out of every 100 cows, costing farmers up to USD 12,771.4 per year due to early culling and reduced milk quality. With such financial risks, farmers are prioritizing preventive vaccination programs to safeguard profitability and herd health.

Growing awareness of animal welfare and improved farm management practices further accelerates vaccine adoption. As consumers demand safer, higher-quality dairy and meat products, producers increasingly rely on immunization to reduce disease occurrence and enhance livestock productivity.

Market Restraints

Limited immunization uptake in developing countries remains a major obstacle. Insufficient veterinary infrastructure, lack of farmer education, and economic challenges reduce vaccination rates. According to FAO data, livestock deaths in developing nations remain high, with 20% of ruminants dying prematurely each year-half of these due to infectious diseases. The lack of consistent vaccination in low-income regions continues to restrain global market expansion.

Market Opportunities

Research and development initiatives are creating opportunities for advanced vaccine technologies. In August 2024, the University of Missouri developed a vaccine targeting bovine anaplasmosis, a devastating tick-borne disease. Biotechnology advancements, such as recombinant vaccines and genomics-based platforms, are enabling faster development of targeted immunizations. This innovation pipeline opens new growth avenues for controlling emerging livestock diseases.

Market Trends

mRNA vaccine development is an emerging trend transforming the veterinary vaccine landscape. These vaccines offer high adaptability, rapid production, and multi-pathogen targeting capabilities. In February 2025, Elanco partnered with Medgene to commercialize an mRNA-based vaccine against Highly Pathogenic Avian Influenza (HPAI) for dairy cattle. Such breakthroughs are expected to reshape bovine disease prevention strategies over the coming decade.

Segmentation Insights

By Product

In 2024, inactivated vaccines held the leading share due to high efficacy and increasing approvals. In May 2024, Boehringer Ingelheim launched BULTAVO 3, an inactivated vaccine against Bluetongue Virus Serotype 3.

By Route of Administration

The parenteral segment dominated in 2024, supported by higher efficacy and rapid immune response. Zoetis' approved Protivity vaccine for Mycoplasma bovis in 2023 reinforced the segment's leadership.

By Distribution Channel

Veterinary hospitals held the largest share due to government-led mass vaccination programs. India's 2025 LHDCP initiative to vaccinate livestock against multiple diseases boosted hospital-based vaccine distribution.

Regional Outlook

North America

The market reached USD 1.76 billion in 2024, driven by strong veterinary infrastructure and increasing dairy production. The U.S. leads the region with extensive R&D investments, including new vaccines for Bovine Respiratory Disease.

Europe

Growth is supported by government-led zoonotic disease control programs and vaccination trials, such as the U.K.'s TB vaccine study launched in 2023.

Asia Pacific

Expected to witness strong growth due to rising dairy production and high disease burden. India forecast 110.7 million metric tons of buffalo milk production in 2024, boosting vaccination requirements.

Latin America & Middle East/Africa

Moderate growth is expected, driven by rising herd populations and governmental immunization campaigns such as Abu Dhabi's 2024-2025 livestock vaccination drive.

Conclusion

With the global market expanding from USD 3.79 billion in 2024 to USD 3.90 billion in 2025, and projected to reach USD 5.46 billion by 2032, the bovine vaccines industry is set for strong long-term growth. Increasing disease prevalence, expanding dairy production, and rapid technological advancements will continue to shape the market's future.

Segmentation By Product

  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Intranasal

By Distribution Channel

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others

By Region

  • North America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.S.
    • Canada
  • Europe (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Route of Administration, Distribution Channel, Country/Sub-Region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Overview of Bovine Diseases by Key Countries, By Key Countries/ Region, 2024
  • 4.2. Regulatory Scenario by Key Countries/ Region, 2024
  • 4.3. Overview of Vaccination for Bovine Diseases
  • 4.4. New Product Launches, By Key Players
  • 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.6. Impact of COVID-19 on the Global Bovine Vaccines Market

5. Global Bovine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Inactivated
    • 5.1.2. Live Attenuated
    • 5.1.3. Recombinant
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 5.2.1. Oral
    • 5.2.2. Parenteral
    • 5.2.3. Intranasal
  • 5.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.3.1. Veterinary Hospitals
    • 5.3.2. Veterinary Clinics
    • 5.3.3. Pharmacies & Drug Stores
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Bovine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Inactivated
    • 6.1.2. Live Attenuated
    • 6.1.3. Recombinant
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 6.2.1. Oral
    • 6.2.2. Parenteral
    • 6.2.3. Intranasal
  • 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.3.1. Veterinary Hospitals
    • 6.3.2. Veterinary Clinics
    • 6.3.3. Pharmacies & Drug Stores
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Bovine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Inactivated
    • 7.1.2. Live Attenuated
    • 7.1.3. Recombinant
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 7.2.1. Oral
    • 7.2.2. Parenteral
    • 7.2.3. Intranasal
  • 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
    • 7.3.3. Pharmacies & Drug Stores
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Bovine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Inactivated
    • 8.1.2. Live Attenuated
    • 8.1.3. Recombinant
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 8.2.1. Oral
    • 8.2.2. Parenteral
    • 8.2.3. Intranasal
  • 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.3.1. Veterinary Hospitals
    • 8.3.2. Veterinary Clinics
    • 8.3.3. Pharmacies & Drug Stores
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Bovine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Inactivated
    • 9.1.2. Live Attenuated
    • 9.1.3. Recombinant
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 9.2.1. Oral
    • 9.2.2. Parenteral
    • 9.2.3. Intranasal
  • 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.3.1. Veterinary Hospitals
    • 9.3.2. Veterinary Clinics
    • 9.3.3. Pharmacies & Drug Stores
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Bovine Vaccines Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Inactivated
    • 10.1.2. Live Attenuated
    • 10.1.3. Recombinant
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Route of Administration
    • 10.2.1. Oral
    • 10.2.2. Parenteral
    • 10.2.3. Intranasal
  • 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.3.1. Veterinary Hospitals
    • 10.3.2. Veterinary Clinics
    • 10.3.3. Pharmacies & Drug Stores
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Elanco
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. HIPRA
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Boehringer Ingelheim International GmbH
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Virbac
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Merck & Co., Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Zoetis Services LLC
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Ceva
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Indian Immunologicals Ltd.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 2: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 3: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 4: Global Bovine Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 5: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 6: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 7: North America Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 8: North America Bovine Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 9: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 10: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 11: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 12: Europe Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 14: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 15: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 16: Asia Pacific Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 17: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 18: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 19: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 20: Latin America Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 22: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
  • Table 23: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
  • Table 24: Middle East & Africa Bovine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Bovine Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Bovine Vaccines Market Value Share (%), by Product, 2024 & 2032
  • Figure 3: Global Bovine Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
  • Figure 4: Global Bovine Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
  • Figure 5: Global Bovine Vaccines Market Value Share (%), by Region, 2024 & 2032
  • Figure 6: North America Bovine Vaccines Market Value (USD billion), by Product, 2024 & 2032
  • Figure 7: North America Bovine Vaccines Market Value Share (%), by Product, 2024
  • Figure 8: North America Bovine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 9: North America Bovine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 10: North America Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 11: North America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 12: North America Bovine Vaccines Market Value (USD billion), By Country, 2024 & 2032
  • Figure 13: North America Bovine Vaccines Market Value Share (%), By Country, 2024
  • Figure 14: Europe Bovine Vaccines Market Value (USD billion), by Product, 2024 & 2032
  • Figure 15: Europe Bovine Vaccines Market Value Share (%), by Product, 2024
  • Figure 16: Europe Bovine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 17: Europe Bovine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 18: Europe Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 19: Europe Bovine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 20: Europe Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 21: Europe Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Bovine Vaccines Market Value (USD billion), by Product, 2024 & 2032
  • Figure 23: Asia Pacific Bovine Vaccines Market Value Share (%), by Product, 2024
  • Figure 24: Asia Pacific Bovine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 25: Asia Pacific Bovine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 26: Asia Pacific Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 27: Asia Pacific Bovine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 28: Asia Pacific Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Bovine Vaccines Market Value (USD billion), by Product, 2024 & 2032
  • Figure 31: Latin America Bovine Vaccines Market Value Share (%), by Product, 2024
  • Figure 32: Latin America Bovine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 33: Latin America Bovine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 34: Latin America Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 35: Latin America Bovine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 36: Latin America Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 37: Latin America Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Product, 2024 & 2032
  • Figure 39: Middle East & Africa Bovine Vaccines Market Value Share (%), by Product, 2024
  • Figure 40: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
  • Figure 41: Middle East & Africa Bovine Vaccines Market Value Share (%), by Route of Administration, 2024
  • Figure 42: Middle East & Africa Bovine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
  • Figure 43: Middle East & Africa Bovine Vaccines Market Value Share (%), by Distribution Channel, 2024
  • Figure 44: Middle East & Africa Bovine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 45: Middle East & Africa Bovine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Bovine Vaccines Market Share (%), By Company, 2024